Home›Search›Blood Immunology & Cellular Therapy

Blood Immunology & Cellular Therapy

Elsevier · United States

eISSN3050-5976

✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ DOAJ-listed52

Total52

Third-party records · how this is calculated · Report an error →

Aims & Scope✦ Inferred from recent articles

This journal focuses on cellular therapies, particularly CAR T-cell therapies, for hematologic malignancies like multiple myeloma and Hodgkin lymphoma. It also covers research into immune tolerance, graft rejection, and the regulatory aspects of decentralized cell manufacturing.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Visit Journal Website

Submission Info

APC Cost$3,000Above median

Peer ReviewAnonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Elsevier

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

3050-5976

✅

Indexed in a trusted database?

DOAJ

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$3,000

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Research Topics (OpenAlex)

CAR-T cell therapy researchLymphoma Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsImmune Cell Function and InteractionCutaneous lymphoproliferative disorders researchAcute Lymphoblastic Leukemia researchT-cell and B-cell ImmunologyHematopoietic Stem Cell TransplantationChronic Lymphocytic Leukemia ResearchBiomedical Ethics and Regulation

Frequently asked questions about Blood Immunology & Cellular Therapy

Is Blood Immunology & Cellular Therapy a predatory journal?

PubScope has no integrity flags on record for Blood Immunology & Cellular Therapy: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood Immunology & Cellular Therapy?

Blood Immunology & Cellular Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.

Is Blood Immunology & Cellular Therapy indexed in Scopus and Web of Science?

Blood Immunology & Cellular Therapy is indexed in DOAJ.

How much does it cost to publish in Blood Immunology & Cellular Therapy?

Blood Immunology & Cellular Therapy charges an article processing charge (APC) of about $3,000 for open-access publication.